Cargando…

Comments on “Relationship between body composition and PBRM1 mutations in clear cell renal cell carcinoma: a propensity score matching analysis”

Detalles Bibliográficos
Autores principales:	Pontes-Silva, André, Kovaleva, Olga, Gadzhiakhmedova3, Aida, Luchina, Anastasia, Sinelnikov, Mikhail, Maslennikov, Roman, Musaeva, Asiyat, Zharova, Nataliya, Zharikova, Tatyana, Zharikov, Yury
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Associação Médica Brasileira 2023
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10508942/ https://www.ncbi.nlm.nih.gov/pubmed/37729382 http://dx.doi.org/10.1590/1806-9282.20230721

Ejemplares similares

Clostridioides difficile infection in patients with nonalcoholic fatty liver disease-current status
por: Kiseleva, Yana V, et al.
Publicado: (2023)

Identifying sex-specific injury predictors as a key factor in maintaining optimal physical activity levels
por: Sankova, Maria V, et al.
Publicado: (2023)

Comments on “Overweight status, abdominal circumference, physical activity, and functional constipation in children”
por: Pontes-Silva, André, et al.
Publicado: (2023)

Mutational Analysis of PBRM1 and Significance of PBRM1 Mutation in Anti-PD-1 Immunotherapy of Clear Cell Renal Cell Carcinoma
por: Aili, Abudureyimujiang, et al.
Publicado: (2021)

Relationship between body composition and PBRM1 mutations in clear cell renal cell carcinoma: a propensity score matching analysis
por: Demirel, Emin, et al.
Publicado: (2023)

Prognostic and Predictive Value of PBRM1 in Clear Cell Renal Cell Carcinoma
por: Carril-Ajuria, Lucía, et al.
Publicado: (2019)

Risk modeling of femoral neck fracture based on geometric parameters of the proximal epiphysis
por: Shitova, Anna D, et al.
Publicado: (2022)

PBRM1 Regulates the Expression of Genes Involved in Metabolism and Cell Adhesion in Renal Clear Cell Carcinoma
por: Chowdhury, Basudev, et al.
Publicado: (2016)

Development and validation of a PBRM1‐associated immune prognostic model for clear cell renal cell carcinoma
por: Chen, Jiayi, et al.
Publicado: (2021)

Anatomical basis for pancreas transplantation via isolated splenic artery perfusion: A literature review
por: Dmitriev, Ilya, et al.
Publicado: (2022)

Context-dependent role for chromatin remodeling component PBRM1/BAF180 in clear cell renal cell carcinoma
por: Murakami, A, et al.
Publicado: (2017)

PBRM1 Regulates Stress Response in Epithelial Cells
por: Porter, Elizabeth G., et al.
Publicado: (2019)

BAP1 and PBRM1 in metastatic clear cell renal cell carcinoma: tumor heterogeneity and concordance with paired primary tumor
por: Eckel-Passow, Jeanette E., et al.
Publicado: (2017)

Involvement of PBRM1 in VHL disease-associated clear cell renal cell carcinoma and its putative relationship with the HIF pathway
por: Gad, Sophie, et al.
Publicado: (2021)

PBRM1 Immunohistochemical Expression Profile Correlates with Histomorphological Features and Endothelial Expression of Tumor Vasculature for Clear Cell Renal Cell Carcinoma
por: Saiga, Kazuho, et al.
Publicado: (2022)

PBRM1 bromodomains associate with RNA to facilitate chromatin association
por: De Silva, Saumya M, et al.
Publicado: (2023)

Molecular pathways of liver regeneration: A comprehensive review
por: Kiseleva, Yana V, et al.
Publicado: (2021)

An integrative genomics approach for identifying novel functional consequences of PBRM1 truncated mutations in clear cell renal cell carcinoma (ccRCC)
por: Wang, Yuanyuan, et al.
Publicado: (2016)

Expression and Mutation Patterns of PBRM1, BAP1 and SETD2 Mirror Specific Evolutionary Subtypes in Clear Cell Renal Cell Carcinoma()
por: Bihr, Svenja, et al.
Publicado: (2019)

Role of the Pbrm1 subunit and the PBAF complex in Schwann cell development
por: Polanetzki, Vanessa, et al.
Publicado: (2022)

A Pan-Cancer Analysis of the Role of PBRM1 in Human Tumors
por: Liu, Jin, et al.
Publicado: (2022)

PBRM1 mutation as a predictive biomarker for immunotherapy in multiple cancers
por: Dai, Jiali, et al.
Publicado: (2023)

Erratum to: An integrative genomics approach for identifying novel functional consequences of PBRM1 truncated mutations in clear cell renal cell carcinoma (ccRCC)
por: Wang, Yuanyuan, et al.
Publicado: (2016)

PBRM1 deficiency oncogenic addiction is associated with activated AKT–mTOR signalling and aerobic glycolysis in clear cell renal cell carcinoma cells
por: Tang, Yu, et al.
Publicado: (2022)

Pbrm1 intrinsically controls the development and effector differentiation of iNKT cells
por: Wang, Xin, et al.
Publicado: (2022)

Aberrant promoter hypermethylation of PBRM1, BAP1, SETD2, KDM6A and other chromatin-modifying genes is absent or rare in clear cell RCC
por: Ibragimova, Ilsiya, et al.
Publicado: (2013)

Adrenocorticotropic hormone-producing pheochromocytoma: A case report
por: Krylov, Vadim, et al.
Publicado: (2020)

Loss of PBRM1 rescues VHL dependent replication stress to promote renal carcinogenesis
por: Espana-Agusti, Judit, et al.
Publicado: (2017)

PBRM1 suppresses tumor growth as a novel p53 acetylation reader
por: Cai, Weijia, et al.
Publicado: (2020)

PBRM1 Cooperates with YTHDF2 to Control HIF-1α Protein Translation
por: Shmakova, Alena, et al.
Publicado: (2021)

PBRM1 suppresses bladder cancer by cyclin B1 induced cell cycle arrest
por: Huang, Li, et al.
Publicado: (2015)

PBRM1 Inactivation Promotes Upregulation of Human Endogenous Retroviruses in a HIF-Dependent Manner
por: Zhou, Mi, et al.
Publicado: (2022)

PBRM1 presents a potential prognostic marker and therapeutic target in duodenal papillary carcinoma
por: He, Xujun, et al.
Publicado: (2022)

Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma
por: Varela, Ignacio, et al.
Publicado: (2011)

PBRM1 and the glycosylphosphatidylinositol biosynthetic pathway promote tumor killing mediated by MHC-unrestricted cytotoxic lymphocytes
por: Menasche, Bridget L., et al.
Publicado: (2020)

PBRM1 acts as a p53 lysine-acetylation reader to suppress renal tumor growth
por: Cai, Weijia, et al.
Publicado: (2019)

Dramatic In Vivo Efficacy of the EZH2-Inhibitor Tazemetostat in PBRM1-Mutated Human Chordoma Xenograft
por: Passeri, Thibault, et al.
Publicado: (2022)

PBRM1 Deficiency Sensitizes Renal Cancer Cells to DNMT Inhibitor 5-Fluoro-2’-Deoxycytidine
por: Gu, Di, et al.
Publicado: (2022)

Biallelic inactivation of PBRM1 as a molecular driver in a rare pineoblastoma case: illustrative case
por: Antonios, Joseph P., et al.
Publicado: (2022)

Coordinated alternation of DNA methylation and alternative splicing of PBRM1 affect bovine sperm structure and motility
por: Yang, Chunhong, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_92ifrk8tps8ld46aj2jq8ls69o